2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
Intravitreal injections (IVI) have become the most common intraocular procedure worldwide with increasing numbers every year. The article presents the most up-to-date review on IVI epidemiology and techniques. Unfortunately, important issues related to pre-, peri- and postinjection management lack randomized clinical trials for a final conclusion. Also, a great diversity of approaches exists worldwide. Therefore, expert consensus recommendations on IVI techniques are provided.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) are the most commonly performed intraocular treatment worldwide [1].”
From Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review (2021) · cites this paper as [1]
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
Mitchell, P., Bandello, F., Schmidt-Erfurth, U., Lang, G. E., Massin, P., Schlingemann, R. O., Sutter, F., Simader, C., Burian, G., Gerstner, O., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.01.031 · Cited by 1,326
Self-citationHaller, J. A., Bandello, F., Belfort, R., Blumenkranz, M. S., Gillies, M., Heier, J., Loewenstein, A., Yoon, Y. H., Jiao, J., Li, X.-Y., et al. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2011.05.014 · Cited by 673
Self-citationRole of External Bacterial Flora in the Pathogenesis of Acute Postoperative Endophthalmitis
Speaker, M. G., Milch, F. A., Shah, M. K., Eisner, W., & Kreiswirth, B. N. (1991) · Ophthalmology · doi:10.1016/s0161-6420(91)32239-5 · Cited by 656
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · Cited by 474
Ranibizumab for Macular Edema Due to Retinal Vein Occlusions
Heier, J. S., Campochiaro, P. A., Yau, L., Li, Z., Saroj, N., Rubio, R. G., & Lai, P. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2011.12.005 · Cited by 470
EVOLVING GUIDELINES FOR INTRAVITREOUS INJECTIONS
AIELLO, L. P., BRUCKER, A. J., CHANG, S., CUNNINGHAM, E. T., D’AMICO, D. J., FLYNN, H. W., GRILLONE, L. R., HUTCHERSON, S., LIEBMANN, J. M., O’BRIEN, T. P., et al. (2004) · Retina · doi:10.1097/00006982-200410001-00002 · Cited by 407
Increased bactericidal activity of dilute preparations of povidone-iodine solutions
Berkelman, R. L., Holland, B. W., & Anderson, R. L. (1982) · Journal of Clinical Microbiology · doi:10.1128/jcm.15.4.635-639.1982 · Cited by 396
Research works printed but not linked: 4
- 10.1001/archophthalmol.2010.297 · DOI
- 10.1097/IAE.0b013e31829f74b0 · DOI
- 10.1097/00006982-200410001-00002 · DOI · Paper page
- 10.1007/s00417-017-3608-y · DOI
Cited by
Items 201–297 of 297
The effect of intravitreal injection into different quadrants on pain score
Güler, Ö., Urfalıoğlu, S., & Güler, M. (2019) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.vi.540726 · Cited by 2
Frolov, M. Y., Salasyuk, A. S., Rogov, V. A., & Astakhov, S. Y. (2021) · Medical Technologies Assessment and Choice · doi:10.17116/medtech20214304159 · Cited by 2
Reducing Injection-Related Safety Events in Retina Clinics
John, D. A., Hansemann, B. K., Lieu, P., & Weizer, J. S. (2022) · Clinical ophthalmology · doi:10.2147/opth.s360628 · Cited by 2
Post-Intravitreal injection pain reduction using topical NSAIDS: A comparative study
Shtayer, C., Smolar, A. L. O., Elmalak, M., Abayev, L., Grzybowski, A. E., & Moisseiev, E. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231201176 · Cited by 2
Self-citationKıvrak, U., Arsan, A. K., Akçay, G., Bulut, M. N., Kanar, H. S., Hacısalihoğlu, A., & Şimşek, Ş. (2024) · International Ophthalmology · doi:10.1007/s10792-024-03134-5 · Cited by 3
“Intravitreal anti-VEGF treatment is the most widely used intraocular procedure worldwide [16].”
Evaluation of intravitreal injections as a risk factor for capsular rupture during cataract surgery
Falb, T., Singer, C., Holter, M., Eder, L., Großpötzl, M., Weger, M., Lindner, E., Berghold, A., Mayer‐Xanthaki, C., Haas, A., et al. (2024) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2024.05.012 · Cited by 2
Intraocular Inflammation Associated with Intravitreal Drug Injections: Current State of the Problem
Валерьевич, Б. Е., Morozova, O. V., Krokhalev, V. Y., & Варежкина, Е. С. (2024) · Офтальмология Восточная Европа · doi:10.34883/pi.2024.14.1.025 · Cited by 2
Kürzere IVOM-Kanüle: eine Verbesserung der Injektionstechnik?
Clemens, C. R., Alten, F., Eter, N., Helbig, H., & Märker, D. (2024) · Die Ophthalmologie · doi:10.1007/s00347-024-02092-8 · Cited by 2
Retinal vasculitis associated with intravitreal bevacizumab injection: A case report
Murillo-Lopez, S., & Medina-Medina, S. (2025) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2025.03.011 · Cited by 2
[Translated article] Consensus on intraocular drug preparations
Garay‐Aramburu, G., Herreros, J. M. A., Izquierdo, M. N., Peiró, J. F. M., Cruchaga, E. V., del Valle, F. G., & Fernández‐Vigo, J. I. (2025) · Farmacia Hospitalaria · doi:10.1016/j.farma.2025.03.004 · Cited by 3
Moreto, R., Cyrino, F. V. R., & Jorge, R. (2020) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00258-5 · Cited by 2
Валерьевич, Б. Е. (2021) · Ophthalmology Reports · doi:10.17816/ov59959 · Cited by 2
Abu‐Ismail, L., Al‐Shami, K., Al-Shami, M., & Nashwan, A. J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1019434 · Cited by 2
Pseudophakia as a surprising protective factor in neovascular age-related macular degeneration
Hanhart, J., Wiener, R., Totah, H., Brosh, K., & Zadok, D. (2023) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2022.11.015 · Cited by 3
Nanoparticles as drug delivery agents for managing diabetic retinopathy
Mukherjee, S., Panda, P., & Mishra, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-820557-0.00014-x · Cited by 2
Impact of Coronavirus Disease 2019 Pandemic on the Epidemiology of Intravitreal Injections
Mirghorbani, M., Esfahani, H. R., Bazvand, F., Bahar, M. M., Yaseri, M., & Zarei, M. (2022) · Journal of Current Ophthalmology · doi:10.4103/joco.joco_253_22 · Cited by 2
“According to the diagnostic code, patients were categorized into 5 groups: (1) Diabetic macular edema (DME)‐related indications, (2) choroidal neovascularization (CNV)/age‐related macular degeneration (AMD)‐related indications, (3) retinal venous occlusion (RVO)‐related indications, (4) retinopathy of prematurity (ROP…”
MethodPhasukkijwatana, N., Jongpipatchai, R., Phuksapaisalsilp, P., Pharkjaksu, S., Ngamskulrungroj, P., & Prakhunhungsit, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-37091-3 · Cited by 2
Mimouni, M., Haim, L. N. B., Rozenberg, E., Shapira, Y., Beiran, I., & Zayit‐Soudry, S. (2020) · Retina · doi:10.1097/iae.0000000000002956 · Cited by 2
Campos, A., Caramelo, F. J., & do Carmo, A. (2019) · Ophthalmology Retina · doi:10.1016/j.oret.2019.03.005 · Cited by 2
Efficacy of Ganciclovir in Cytomegalovirus Retinitis via Intravitreal Route in AIDS Patients
Naz, U., Naz, S., Fahad, H. M., & Rizvi, S. F. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.12.1597 · Cited by 1
Dai, Y., Lou, J., Wen, J., Liang, G.-L., Xu, J., Jing, Z., & Wang, J. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1712378 · Cited by 1
Pastore, M. R., Verdimonti, E., Idrissi, K. E. M. E., Presotto, M., Borelli, M., Mière, A., Tognetto, D., & Souied, E. H. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01289-7 · Cited by 1
“Intravitreal injections (IVI) are widely used in the management of several ocular conditions, including age-related macular degeneration, diabetic macular edema, and retinal vein occlusion, with an estimated 6 million procedures performed annually in the United States [1].”
Kumar, A., Babu, A. B., & Flarence, M. R. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02050-8 · Cited by 1
Ziemssen, F., Loewenstein, A., & Aslam, T. M. (2026) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2026.02.007 · Cited by 2
Self-citationStimuli-responsive hydrogels for ocular tumor therapy
Han, D., Peng, H., Chan, S. Y., Qian, J., Zhou, X., & Luo, Z. (2026) · Micro Nano Science · doi:10.20517/mns.2025.10 · Cited by 1
Jackson, T. L., Desai, R., Wafa, H. A., Lee, C. N., Wang, Y., Peacock, J. L., Pető, T., Chakravarthy, U., Zhu, X. K., Dakin, H., et al. (2026) · BMJ · doi:10.1136/bmj-2026-729694 · Cited by 1
“Anti-VEGF drugs are delivered by long term intravitreal injections, which are the most common eye procedure in many developed nations 2 and carry”
Vitrectomy Status Alters Early Intravitreal Drug Distribution: An Ex Vivo PET-CT Study
Wohlfart, S., Roettgen, H. G., Junker, N., Augustin, V. A., Ackermann, B. C., Geisweid, L., Auffarth, G. U., Mier, W., Uhl, P., & Hammer, M. (2026) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.67.8.36 · Cited by 1
Kaymaz, A., Ulaş, F., Soydan, A., & Toprak, G. (2021) · Journal of Surgery and Medicine · doi:10.28982/josam.901604 · Cited by 1
Novel Combined Lidocaine/Povidone Iodine Delivery System for Preintravitreal Injection
Ziaei, P., Resnick, J. L., Stella, N. A., & Fedorchak, M. V. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0095 · Cited by 1
Immediately sequential bilateral cataract surgery in Down syndrome
Sharma, R. K., Shankar, S., Kumar, N., & Vichhare, N. (2022) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_1166_22 · Cited by 1
Aflibercept monotherapy or bevacizumab first for diabetic macular edema
Hostovsky, A., Moroz, I., & Katz, G. (2024) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_2107_23 · Cited by 2
Navel, V., Labétoulle, M., Lazreg, S., Brémond‐Gignac, D., & Chiambaretta, F. (2024) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2024.104170 · Cited by 1
Daradkeh, D. T., Smadi, F., Haddad, H. K., Smadi, A. A., Habashneh, S. Y., & Shawareb, Z. A. (2024) · Cureus · doi:10.7759/cureus.70297 · Cited by 1
“A possible explanation is a direct puncture of the posterior capsule during the injection as we inject bevacizumab 4 mm posterior to the limbus in phakic eyes [16-17].”
BackgroundIs YouTube a reliable source of education for the intravitreal injection procedure?
Kıvrak, U., Akçay, G., & Gün, R. D. (2024) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2024.104294 · Cited by 1
Jian, H., Wang, T., & Pujara, C. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13466-1.00015-5 · Cited by 1
Risk of ptosis following eyelid speculum assisted intravitreal anti-VEGF injections
Berco, E., Ostrovsky, M., Esomchukwu, O., Zaks, O., Schlesinger, M., Molina, E. J. C., Zaken, S. G. B., & Shoham-Hazon, N. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06763-3 · Cited by 1
Bittner, B., & Schmidt, J. F. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823741-0.00007-5 · Cited by 1
Effect of intravitreal injections on the progression and prognosis of primary open-angle glaucoma
Movsisyan, A. B., Геннадьевна, Г. Н., Brezhnev, A. Y., & Kuroyedov, А. V. (2021) · Russian Journal of Clinical Ophthalmology · doi:10.32364/2311-7729-2021-21-4-227-234 · Cited by 1
Lee, J. E. H., Subramanian, S., Hussein, A., Razali, K. M., & Ngoo, Q. Z. (2022) · Malaysian Journal of Medicine and Health Sciences · doi:10.47836/mjmhs.18.5.20 · Cited by 1
Xu, L. T., Price, K. W., Ramos, M. S., Nowacki, A. S., Yuan, A., & Yan, J. (2023) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264231200738 · Cited by 1
Kustra, A., & Święch-Zubilewicz, A. (2023) · OphthaTherapy Therapies in Ophthalmology · doi:10.24292/01.ot.271923 · Cited by 1
Effects of Intravitreal Injection Bevacizumab in Posterior Segment Vasculopathies - A Clinical Study
Mane, A., Karambelkar, V. H., Gadre, G., & Kadam, S. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23905161226 · Cited by 1
A surge in ocular infection amid COVID-19 pandemic: A reality or a co-incidence?
Khalili, M. R., & Jahanbani‐Ardakani, H. (2020) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2020.12.001 · Cited by 1
Intraokulare Entzündung nach IVOM
Feltgen, N. (2019) · Kompass Ophthalmologie · doi:10.1159/000496175
2019 Update in Retinal Pharmacotherapies
Grzybowski, A. E., Schwartz, S. G., & Kanclerz, P. (2019) · Current Pharmaceutical Design · doi:10.2174/138161282441190320140728
Self-citationOcular complications in pre-eclampsia
Talib, D. N. A., Wagimon, W., Naffi, A. A., Nasaruddin, R. A., Che-Hamzah, J., Omar, M. H., & Din, N. M. (2020) · Malaysian Journal of Ophthalmology · doi:10.35119/myjo.v2i1.66
Letter to the Editor: Evolving Guidelines for Intracameral Injection
Grzybowski, A. E., & Kanclerz, P. (2020) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001708
Self-citationCrim, N., Espósito, E., Barros-Centeno, M. F., González-Castellanos, M. E., Guantay, C. D., González-Castellanos, A., Martínez, D., Irós, M., Daponte, P., & Urrets‐Zavalía, J. A. (2020) · Oftalmología clínica y experimental. · doi:10.70313/2718.7446.v13.n3.30
Han, J. Y., Kang, H. G., Choi, E. Y., Lee, S. C., & Kim, M. (2020) · Journal of Retina · doi:10.21561/jor.2020.5.2.79
Falavigna, L., Scheid, K. L., Lavinsky, D., & Mallmann, F. (2021) · Clinical & Biomedical Research · doi:10.22491/2357-9730.105451 · Cited by 1
Antaki, F., Milad, D., & Dirani, A. (2021) · Clinical ophthalmology · doi:10.2147/opth.s303551
Han, J. Y., Lee, D. H., Kim, J. D., Choi, E. Y., & Kim, M. (2021) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2021.62.6.798
COVID-19 in the Intravitreal Injection (IVI) Procedure at a Spanish Urban Tertiary HospitalPreprint
Fernández, J. J. C., García, M. M. P. A., Sánchez, F. J. M.-A., & González-Guijarro, J. J. (2021) · Research Square · doi:10.21203/rs.3.rs-526020/v1
Movsisyan, A. B., & Egorov, А. Е. (2021) · Russian Journal of Clinical Ophthalmology · doi:10.32364/2311-7729-2021-21-3-159-163
Short-term Safety Evaluation of Resident-performed Intravitreal Injection
Bae, Y. H., Kim, H. K., Bae, S. H., Yoon, C. K., & Ma, D. J. (2021) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2021.62.11.1509
Effect of Intravitreal Triamcinolone (IVT) Injection on Visual Acuity in Patients with Ischemic CRVO
din, S., Khan, Z., Khan, M. A., ., A., Aziz, A., & Chaudhari, M. Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs221611463
Results of the treatment of patients with exudative AMD during the COVID-19 pandemic
Arruabarrena, C., Montejano-Milner, R., de Aragón, F., Allendes, G., & Teus, M. A. (2022) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2021.02.012
Managing proliferative diabetic retinopathy in a patient with vitreous hemorrhage: a case report
Koshchynets, O. B., & Vadiuk, R. L. (2022) · Oftalmologicheskii Zhurnal · doi:10.31288/oftalmolzh202235457
Protocolo Assistencial de Injeções Intravítreas do HCPA: Edema Macular Diabético
Falavigna, L., Scheid, K. L., Lavinsky, D., & Mallmann, F. (2022) · Clinical & Biomedical Research · doi:10.22491/2357-9730.117199
Mehanna, C.-J., Souied, E. H., Coscas, F., Razavi, S., & Cohen, S. Y. (2023) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2023.03.002
Intravitreal Injections for Pediatric Retinal Diseases
Soekamto, C., Rosignoli, L., & Harper, C. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-14506-3_11
Zografos, L. J., Andrews, E. B., Wolin, D., Calingaert, B., Davenport, E. K., Michel, A., Latocha, M., Schmidt-Ott, U., Lovic, N., Brunck, L. R., et al. (2023) · Pharmaceutical Medicine · doi:10.1007/s40290-023-00506-7
Barbosa, R. C., Gonçalves, R., Viana, A. R., Gonçalves, R., & Tenedório, P. (2023) · The Pan-American Journal of Ophthalmology · doi:10.4103/pajo.pajo_70_23
Efficacy of Anti-VEGF in Treatment of Retinopathy of Prematurity
-, R. G. (2024) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2024.v06i01.14342
Orhan, F. T. (2024) · European eye research · doi:10.14744/eer.2023.13007 · Cited by 1
“[19-21] No shift or no intensity change was observed in groups 1079 and 1008 cm -1 The decreasing intensity was observed at 1008 cm -1 .”
BackgroundInfluentialAbbasi, K. Z., Jameel, A., Khan, M. R., Mirza, B. H., Tariq, S., & Abbasi, M. S. R. (2024) · Journal of Rawalpindi Medical College · doi:10.37939/jrmc.v28i1.2449
Vasculitis retiniana asociada a inyección intravítrea de bevacizumab: reporte de caso
Murillo-Lopez, S., & Medina-Medina, S. (2025) · Archivos de la Sociedad Española de Oftalmología · doi:10.1016/j.oftal.2024.10.013
Survey: Practice patterns of intravitreal injection in Japan
Matsuura, K., Sasaki, S.-I., Inoue, H., Mori, T., & Sugihara, K. (2025) · Asia-Pacific Journal of Ophthalmology · doi:10.1016/j.apjo.2025.100169
Treatment of AMD-related macular neovascularization in a patient with silicone oil tamponade
Parisi, G., Gelormini, F., Vallino, V., Ricardi, F., Marolo, P., Borrelli, E., de Sanctis, U., & Reibaldi, M. (2025) · European Journal of Ophthalmology · doi:10.1177/11206721251333273
Torres-Villaros, H., Giocanti‐Auregan, A., Doan, S., Agard, É., Billant, J., Arbousoff, N., Matagrin, B., Fenniri, I., & Dot, C. (2025) · Ophthalmology and Therapy · doi:10.1007/s40123-025-01201-3 · Cited by 1
“IVIs were given according to standard proce‑ dures and Euretina expert consensus [17], using the same procedure in both departments.”
Impact of a laminar air flow portable device on post-intravitreal injection endophthalmitis rate
Airaldi, M., Parrulli, S., Trinco, A., Cinus, F., Staurenghi, G., Pellegrini, M., & Cereda, M. G. (2025) · British Journal of Ophthalmology · doi:10.1136/bjo-2025-327316
Gatsu, M. V., Boiko, E. V., Sharma, A. A., Khizhnyak, I. V., Skumina, E. V., Aleksanina, T. P., Zaika, I. T., & Abramova, E. A. (2025) · Ophthalmology Reports · doi:10.17816/ov678735
Ajlan, R., Dalla, S., Parikh, R. J., Pfannenstiel, M., Champion, M. T., Rahman, M. A., & Díaz, F. J. (2025) · Journal of Ophthalmology · doi:10.1155/joph/6629976 · Cited by 1
“0.1%–1.0% PI have lower iodine reserves and therefore require multiple applications, compared to 2.5%–10% PI, which have abundant iodine reserves and only require a single application [5].”
InfluentialIntravitreal injection delivered volume under different environmental and training conditions
dos Santos, M. L., Santos, L., Cardoso, A. L., Agra, L. L. D. M., Coelho, J. A. P. D. M., & Melo, G. B. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-07005-2
Salom, D., Adloff-Alonso, A., Aguilá, M. S., Martínez-Rubio, C., Janicka-Caulineau, A., Moro-Muniz, M., & Rodrigo, R. (2026) · Infection Prevention in Practice · doi:10.1016/j.infpip.2026.100507
“Anti vascular endothelial growth factor (Anti-VEGF) medication injections have revolutionized the treatment of AMD, significantly improving patients’ visual outcomes [1].”
Mikailova, M. T., Zakieva, S. I., & Magomedova, M. M. (2026) · Russian Ophthalmological Journal · doi:10.21516/2072-0076-2025-18-4-132-138
Tiosano, A., Mekaiten, O., Golan, N., Ishai, M. B., & Schaap‐Fogler, M. (2026) · International Ophthalmology · doi:10.1007/s10792-026-03952-9
“In recent years, the number of intravitreal injections has increased significantly, from 6 million in 2016 to an estimated 15 million annually in the United States alone in 2024 [1, 2].”
Szabó, Á., Thury, G., Baranyi, N., Rárosi, F., Szabó, D. J., Gale, A. G., Tóth‐Molnár, E., & Kovács, A. (2026) · Scientific Reports · doi:10.1038/s41598-026-38455-1
Quadrant-Specific Pain in Intravitreal Injection: A Systematic Review and Meta-analysis
Sabaner, M. C., Gunes, I., Divarcı, A., Anguita, R., van Dijk, E. H. C., Desideri, L. F., Cehofski, L. J., & Subhi, Y. (2026) · Ophthalmology and Therapy · doi:10.1007/s40123-026-01342-z · Cited by 1
“Intravitreal injection (IVI) is among the most frequently performed ophthalmic procedures worldwide [1–3].”
Borkenstein, A. F. M., Borkenstein, E.-M., & Lira, R. P. N. (2026) · Clinical ophthalmology · doi:10.2147/opth.s584374
Basics of Intraocular Pharmacotherapy
Melo, G. B., & Badaró, E. (2026) · Springer eBooks · doi:10.1007/978-3-031-29358-0_17-1
Sanad, A. M., Wessam, M., Saleh, M. I., Elawamry, A. I., & El-Raggal, T. M. (2026) · Journal of the Egyptian Ophthalmological Society · doi:10.4103/ejos.ejos_73_25
Tracer Techniques in Ophthalmology: Ocular Applications and Systemic Connections
Ye, X., Zhao, L., Zhou, X., Wu, W., Lu, Y., Li, Y., Yin, Y., Hu, T., & Wen, D. (2026) · Diagnostics · doi:10.3390/diagnostics16111608
Loewenstein, A., Schmidt-Ott, U., Diana, V., Lanzetta, P., Leal, S., Berliner, A. J., Chu, K. W., Barakat, M. R., Ghorayeb, G. R., Stewart, M. W., et al. (2026) · Ophthalmology and Therapy · doi:10.1007/s40123-026-01424-y · Cited by 2
“Increased IOP after intravitreal injections has been associated with a range of factors, includ‑ ing needle gauge, speed of injection, drug properties, and number of injections over time [23–26].”
InfluentialSelf-citationChang, P. S., Abou-Samra, A., Chun, D. W., Melamud, A., Levinson, J. D., Do, B. K., Huang, J. M., Sobol, E. K., & Ali, M. H. (2026) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264261467251
Tomemori, R., Araki‐Sasaki, K., Kanagawa, T., Ohnaka, M., Hisatsune, J., Higasa, K., & Imai, H. (2026) · Antibiotics · doi:10.3390/antibiotics15080744
Panebianco, L., & Stocchino, A. (2026) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-026-07421-y
Sivaprasad, S., Stewart, M. W., Wykoff, C. C., Eichenbaum, D. A., Korobelnik, J., Lanzetta, P., Chaudhary, V., Cheung, C. M. G., Gale, R. P., Munk, M. R., et al. (2026) · Eye · doi:10.1038/s41433-026-04779-5
Self-citationCost-neutral adoption of anti-VEGF therapies in neovascular age-related macular degeneration
Pitsillidou, O., Petrou, P., & Postma, M. J. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2717293
Nachhaltigkeit intravitrealer Injektionen
Yang-Seeger, D., Ong, A. Y., Issa, P. C., & Birtel, J. (2026) · SDG - Forschung, Konzepte, Lösungsansätze zur Nachhaltigkeit · doi:10.1007/978-3-662-71322-8_10
Silitonga, A. R., Silitonga, H. T. H., Virgana, R., Iskandar, E., Kartasasmita, A., Ihsan, G., & Widyanatha, M. I. (2026) · Cureus · doi:10.7759/cureus.116153
Kobos, E., & Leszczyńska, K. (2026) · Nursing Open · doi:10.1002/nop2.70856
“The frequency and number of injections over the course of treatment vary from patient to patient (Grzybowski et al. 2018; Lam et al. 2021).”
Hollow Microneedles in Ophthalmology: From Drug Delivery to Integrated Biosensing
Sun, F., Xiao, C., Wang, Z., Hu, W., Peng, Z., Wong, Z. J., Tan, Z., & Cui, B. (2026) · Small · doi:10.1002/smll.75520
Vélez-Montoya, R., Franco-Ramirez, K. C., Vargas-Fernández, A. T., Arreola-Martinez, J., Cruz-Cervantes, J. A., Vanzzini-Zago, V., & Fromow-Guerra, J. (2026) · Journal of Ophthalmology · doi:10.1155/joph/6924280
Basics of Intraocular Pharmacotherapy
Melo, G. B., & Badaró, E. (2026) · Springer eBooks · doi:10.1007/978-3-032-23052-2_17
Coskun, H., Mikha, K. N., Rasmussen, C., Andreasen, J. R., Virgili, G., & Kolko, M. (2026) · Acta Ophthalmologica · doi:10.1111/aos.70242
Swinging vs Flicking: Assessing Safer Removal Techniques for Air Bubbles in Intravitreal Injections
Fukuhara, P. S., Lucas, A., Mallela, K. M. G., Jørstad, Ø. K., Farah, M. E., & Melo, G. B. (2026) · Journal of VitreoRetinal Diseases · doi:10.1177/24741264261495458
Metadata
- Authors
- Grzybowski, A., Told, R., Sacu, S., Bandello, F., Moisseiev, E., Loewenstein, A., Schmidt-Erfurth, U., & on behalf of the Euretina Board
- Affiliations
- Foundation for the Development of Ophthalmology (PL)
- Medical University of Vienna (AT)
- Vita-Salute San Raffaele University (IT)
- Tel Aviv University (IL)
- ORCID
- Venue
- Ophthalmologica
- Publisher
- S. Karger AG
- Published
- 2018
- Volume
- 239
- Issue
- 4
- Pages
- 181-193
- ISSN
- 0030-3755 (ISSN-L)
- 1423-0267
- OpenAlex
- W2789582799
- Cited by
- 297
- References
- 139
- Citations by year
- 2026: 31 · 2025: 28 · 2024: 29 · 2023: 26 · 2022: 37 · 2021: 58 · 2020: 58 · 2019: 26 · 2018: 3
- FWCI
- 36.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Ophthalmologica (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal and Macular Surgery
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- intravitreal injection, injection technique, expert consensus recommendations
- MeSH terms
- Europe, Humans, Retinal Diseases, Visual Acuity, Practice Guidelines as Topic, Consensus, Intravitreal Injections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.